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Abstract
Cyclooxygenase-2 (COX-2) inhibitor nimesulide inhibits the proliferation of
various types of cancer cells mainly via COX-2 independent mechanisms, which
makes it a good lead compound for anti-cancer drug development. A series of
new nimesulide analogs were evaluated with cell proliferation assay based on a
non-small lung cancer cell line H292. The results showed that several
derivatives were very active to against H292 cell growth with IC50s of sub nano
mole. These results suggest the possibility of using these nimesulide derivatives
as chemo preventive agents. It has been proved that these compounds bind to
tubulin and Hsp27 in the tumor cells, which presumably explains the potent anticancer activity of the compounds. However, it is still unclear either tubulin or
Hsp27 mainly contributed to the anti-cancer activity. It is also possible that
these two molecular targets of the compounds exhibited synergistic effects.
Further investigations are needed to elucidate the molecular mechanism of the
novel anti-cancer agents.

